Successful treatment of aggressive AA amyloidosis with tocilizumab in a patient with polymyalgia rheumatica

被引：0
|
作者：
Atas, Nuh [1 ]
Caliskan, Ali Riza [2 ]
Akatli, Aysenur [3 ]
机构：
[1] Adiyaman Educ & Res Hosp, Dept Internal Med, Div Rheumatol, TR-2230 Adiyaman, Turkiye
[2] Adiyaman Educ & Res Hosp, Dept Internal Med, Div Gastroenterol, Adiyaman, Turkiye
[3] Inonu Univ, Fac Med, Dept Pathol, Malatya, Turkiye
来源：
MODERN RHEUMATOLOGY CASE REPORTS | 2024年
关键词：
Polymyalgia rheumatica; AA amyloidosis; tocilizumab; IL-6; proteinuria; SECONDARY;
D O I：
10.1093/mrcr/rxae050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Polymyalgia rheumatic (PMR) associated amyloidosis is an extremely rare condition that can be rapidly progressive with high morbidity and mortality and management is challenging. Tocilizumab is a monoclonal anti-IL-6 receptor antibody, which is in the therapeutic arsenal of PMR. The efficiency of tocilizumab in improvement of PMR activity score and decreasing steroid dose is well-established, while efficiency in PMR-associated amyloidosis has not been published. Herein, we reported a PMR patient with amyloid A amyloidosis who was treated effectively with tocilizumab.
引用
收藏
页码：214 / 217
页数：4
相关论文
共 50 条
  • [1] RAPID DEVELOPMENT OF RENAL FAILURE SECONDARY TO AA-TYPE AMYLOIDOSIS IN A PATIENT WITH POLYMYALGIA RHEUMATICA
    Javaid, Muhammad Masoom
    Kamalanathan, Manivarma
    Sui Phin Kon
    JOURNAL OF RENAL CARE, 2010, 36 (04) : 199 - 202
  • [2] Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
    Farinango, Michelle
    Ansary, Akhil
    Dakka, Amulya
    Nazir, Zahra
    Shamim, Humaira
    Jean, Marie
    Umair, Muaaz
    Muddaloor, Pratyusha
    Chavarria, Yeny
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [3] Tocilizumab-Induced Sweet Syndrome in a Patient With Polymyalgia Rheumatica
    Filippi, Federica
    Chessa, Marco A.
    Patrizi, Annalisa
    Baraldi, Carlotta
    Ferrara, Francesca
    Bardazzi, Federico
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2020, 10 (01):
  • [4] AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab
    Hocevar, Alojzija
    Lestan, Boris
    Semrl, Snezna Sodin
    Lakota, Katja
    Kojc, Nika
    Potocnik, Natasa
    Tomsic, Matija
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2013, 20 (04): : 275 - 276
  • [5] Effective Control of Polymyalgia Rheumatica With Tocilizumab
    Al Rashidi, Abdulrahman
    Hegazi, Mohamed Osama
    Mohammad, Shaimaa A.
    Varghese, Alex
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (07) : 400 - 401
  • [6] Successful treatment with clarithromycin for patients with polymyalgia rheumatica
    Ohe, Masashi
    Bohgaki, Toshiyuki
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (04) : 539 - 541
  • [7] Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab
    Kovacs, Attila
    Cserenyecz, Anita
    Baksay, Beata
    Kemeny, Eva
    Szekanecz, Zoltan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (07): : 389 - 391
  • [8] Tocilizumab controls bone turnover in early polymyalgia rheumatica
    Alegria, Guillermo Carvajal
    Garrigues, Florent
    Bettacchioli, Eleonore
    Loeuille, Damien
    Saraux, Alain
    Cornec, Divi
    Devauchelle-Pensec, Valerie
    Renaudineau, Yves
    JOINT BONE SPINE, 2021, 88 (03)
  • [9] Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review
    Akiyama, Mitsuhiro
    Kaneko, Yuko
    Takeuchi, Tsutomu
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (03) : 521 - 525
  • [10] Successful treatment of AA amyloidosis with tocilizumab, resulting in the disappearance of amyloid deposits: a case-based review
    Tortosa-Cabanas, Marina
    Batlle, Jose Acosta
    Perna, Cristian
    Bachiller-Corral, Javier
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
12345